Literature DB >> 22283456

Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.

Tetsuya Shimoyama1, Kunihiko Itoh, Michiya Kobayashi, Shozo Miyazaki, Antony D'Emanuele, David Attwood.   

Abstract

BACKGROUND: Elderly patients with swallowing dysfunction may benefit from the oral administration of liquid dosage forms with in situ gelling properties. AIM: We have designed in situ gelling liquid dosage formulations composed of mixtures of methylcellulose, which has thermally reversible gelation properties and sodium alginate, the gelation of which is ion-responsive, with suitable rheological characteristics for ease of administration to dysphagic patients and suitable integrity in the stomach to achieve a sustained release of drug.
METHOD: The rheological and gelation characteristics of solutions containing methylcellulose (2.0%) and sodium alginate (0.25-1.0%) were assessed for their suitability for administration to dysphagic patients. The gel strength and in vitro and in vivo release characteristics of gels formed by selected formulations were compared using paracetamol as a model drug.
RESULTS: Mixtures of 2.0% methylcellulose and 0.5% alginate containing 20% d-sorbitol were of suitable viscosity for ease of swallowing by dysphagic patients and formed gels at temperatures between ambient and body temperature allowing administration in liquid form and in situ gelation in the stomach. In vitro release of paracetamol from 2.0% methylcellulose/0.5% alginate gels was diffusion-controlled at pH 1.2 and 6.8. Measurement of plasma levels of paracetamol after oral administration to rats of a 2.0% methylcellulose/0.5% alginate formulation showed improved sustained release compared to that from 2.0% methylcellulose and 0.5% alginate solutions and from an aqueous solution of paracetamol.
CONCLUSIONS: Solutions of mixtures of methylcellulose and alginate in appropriate proportions are of suitable consistency for administration to dysphagic patients and form gels in situ with sustained release characteristics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283456     DOI: 10.3109/03639045.2011.634809

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Risedronate-Loaded Macroporous Gel Foam Enriched with Nanohydroxyapatite: Preparation, Characterization, and Osteogenic Activity Evaluation Using Saos-2 Cells.

Authors:  Nadia M Morsi; Rehab Nabil Shamma; Nouran Osama Eladawy; Abdelfattah A Abdelkhalek
Journal:  AAPS PharmSciTech       Date:  2019-02-08       Impact factor: 4.026

2.  Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.

Authors:  Samar M Abouelatta; Ahmed A Aboelwafa; Omaima N El-Gazayerly
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.